Showing 1 - 7 results of 7 for search 'Peter G. M. Mol', query time: 0.05s
Refine Results
-
1
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study by Sonia Roldan Munoz, Douwe Postmus, Sieta T. de Vries, Arna H. Arnardottir, İlknur Dolu, Hans Hillege, Hans Hillege, Peter G. M. Mol, Peter G. M. Mol
Published 2021Connect to this object online.
Book -
2
A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe by Jeroen V. Koomen, Jeroen V. Koomen, Jasper Stevens, Margje H. Monster-Simons, Margje H. Monster-Simons, Hiddo J. L. Heerspink, Peter G. M. Mol, Peter G. M. Mol
Published 2021Connect to this object online.
Book -
3
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting by Elisabeth Bakker, Peter G. M. Mol, Peter G. M. Mol, Peter G. M. Mol, João Nabais, João Nabais, Thorsten Vetter, Matthias Kretzler, John J. Nolan, Gert Mayer, Anna K. Sundgren, Hiddo J. L. Heerspink, Anja Schiel, Anja Schiel, Sieta T. de Vries, Maria F. Gomez, Friedrich Schulze, Dick de Zeeuw, Michelle J. Pena, for the BEAt-DKD Consortium
Published 2021Connect to this object online.
Book -
4
Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020 by Elisabeth Bakker, Viktoriia Starokozhko, Jet W. M. Kraaijvanger, Hiddo J. L. Heerspink, Peter G. M. Mol
Published 2023Connect to this object online.
Book -
5
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment by Rianne A. Weersink, Rianne A. Weersink, Lotte Timmermans, Lotte Timmermans, Margje H. Monster-Simons, Margje H. Monster-Simons, Peter G. M. Mol, Peter G. M. Mol, Herold J. Metselaar, Sander D. Borgsteede, Sander D. Borgsteede, Katja Taxis
Published 2019Connect to this object online.
Book -
6
The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series study by Fatma Karapinar-Çarkıt, Sander D. Borgsteede, Marjo J. A. Janssen, Marlies Mak, Nimet Yildirim, Carl E. H. Siegert, Peter G. M. Mol, Toine C. G. Egberts, Patricia M. L. A. van den Bemt
Published 2019Connect to this object online.
Book -
7
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire by Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, Walter Van Dyck, Steven Simoens, Isabelle Huys, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G.M. Mol, Anja Schiel, Wim Goettsch, Fabrizio Gianfrate, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Elaine Julian
Published 2023Connect to this object online.
Book